Northstar Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Northstar Wealth Partners's PFE Position: Q3 2020 in Review
Northstar Wealth Partners reduced its Pfizer (PFE) stake by 1.7% in Q3 2020, selling an estimated $102K and leaving 167,343 shares worth $5.83M. The position accounts for 2.72% of the portfolio, ranked #5.
Northstar Wealth Partners first reported a position in PFE in Q1 2017 and has held it in 15 quarters since. The position peaked at $6.29M in Q4 2019. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.
- Northstar Wealth Partners held 167,343 shares of Pfizer worth $5.83M as of Q3 2020.
- Northstar Wealth Partners sold 2,904 Pfizer shares in Q3 2020, an estimated $102K.
- Pfizer made up 2.72% of Northstar Wealth Partners's portfolio in Q3 2020, its #5 holding.
- Northstar Wealth Partners first reported a position in Pfizer in Q1 2017 and has held it in 15 quarters since.
- Northstar Wealth Partners's Pfizer position peaked at $6.29M in Q4 2019.
- 2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.
Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.